Freshly isolated virulent and nonvirulent strains of Streptococcus agalactiae type III were used to study differences in coccal adherence to synchronously dividing, subconfluent human embryonic amnion and fetal lung monolayers in vitro. The adherence frequency by virulent isolates of mid-logarithmically growing cocci to amnion cells varied markedly with host cell age, being highest shortly after eucaryotic cell division. This variation was not observed with lung cell monolayers, suggesting that cyclic production or exposure of coccal receptor sites on the eucaryotic cell surface with age is not a common property of all primary human cells in vitro. However, and regardless of age, not all cells within these synchronously dividing populations bound virulent cocci, indicating that a very small segment of a population may always be unresponsive to host cell interactions with a coccal pathogen. By comparison, adherence of nonvirulent coccal isolates to amnion and lung cells remained constant and of a very low order, regardless of host cell age. Maximal adherence of virulent S. agalactiae to young host cells occurred at early and mid-logarithmic phases of growth. However, at the late stationary growth phase, adherence was reduced to almost that of nonvirulent isolates. Pretreatment of virulent S. agalactiae with anti-lipoteichoic acid (LTA) serum failed to inhibit coccal adherence to these different host cells. Heat negated adherence. Group B coccal LTA was cytotoxic for these host cells. However, pretreatment of amnion and lung cells with nontoxic levels of this amphiphile did not prevent attachment of virulent cocci. Finally, coccal pretreatment with pronase abrogated adherence to either host cell even though surface-exposed LTA was uneffected, as observed by the indirect fluorescent-antibody procedure. Likewise, no observable difference in surface LTA was detected when fresh isolates of virulent and nonvirulent coccal strains were compared by this procedure. These studies suggest that protein involvement, rather than LTA, is primarily responsible for mediating virulent S. agalactiae type III attachment to these synchronously growing, subconfluent eucaryotic monolayers in vitro.
Freshly isolated virulent and nonvirulent strains of Streptococcus agalactiae type III were used to study differences in coccal adherence to synchronously dividing, subconfluent human embryonic amnion and fetal lung monolayers in vitro. The adherence frequency by virulent isolates of mid-logarithmically growing cocci to amnion cells varied markedly with host cell age, being highest shortly after eucaryotic cell division. This variation was not observed with lung cell monolayers, suggesting that cyclic production or exposure of coccal receptor sites on the eucaryotic cell surface with age is not a common property of all primary human cells in vitro. However, and regardless of age, not all cells within these synchronously dividing populations bound virulent cocci, indicating that a very small segment of a population may always be unresponsive to host cell interactions with a coccal pathogen. By comparison, adherence of nonvirulent coccal isolates to amnion and lung cells remained constant and of a very low order, regardless of host cell age. Maximal adherence of virulent S. agalactiae to young host cells occurred at early and mid-logarithmic phases of growth. However, at the late stationary growth phase, adherence was reduced to almost that of nonvirulent isolates. Pretreatment of virulent S. agalactiae with anti-lipoteichoic acid (LTA) serum failed to inhibit coccal adherence to these different host cells. Heat negated adherence. Group B coccal LTA was cytotoxic for these host cells. However, pretreatment of amnion and lung cells with nontoxic levels of this amphiphile did not prevent attachment of virulent cocci. Finally, coccal pretreatment with pronase abrogated adherence to either host cell even though surface-exposed LTA was uneffected, as observed by the indirect fluorescent-antibody procedure. Likewise, no observable difference in surface LTA was detected when fresh isolates of virulent and nonvirulent coccal strains were compared by this procedure. These studies suggest that protein involvement, rather than LTA, is primarily responsible for mediating virulent S. agalactiae type III attachment to these synchronously growing, subconfluent eucaryotic monolayers in vitro.
Streptococcus agalactiae was first linked to human disease in 1938 (8) . Currently, this organism is considered a leading pathogen, most frequently causing neonatal sepsis, meningitis, and respiratory problems. Yet, its increase in incidence in the neonatal population remains obscure (11) . Therefore, any knowledge of the biological properties of this organism is important, since 50% of all infants infected by this organism die and an equal proportion of survivors of meningeal invasion have neurological sequelae. Adherence is a prerequisite for successful colonization of normal flora, as well as pathogenic group B streptococci (GBS). Also, selectivity in adherence probably accounts for the tissue tropism usually exhibited by most organisms, including this pathogen. In this regard, it has been established that the amphiphile lipoteichoic acid (LTA) is instrumental in the colonization or adherence of S. pyogenes to human cells (1, 7, 12, 18, 22) .
The role of LTA in the adherence of S. agalactiae to human cells is not as clearly defined. For example, it had been reported that virulent GBS type III contained significantly more LTA than did nonvirulent GBS of the same serotype and that the former exhibited the highest levels of LTA at the late exponential to early stationary phases of growth (16, 17) . Also, whereas both of these coccal types adhered to human cell suspensions in vitro via an LTA-ically as S. agalactiae by us, and each was identified serologically as type III by Richard R. Facklam, Centers for Disease Control, Atlanta, Ga. Also, a virulent S. agalactiae type III strain (DS2242-77) was obtained from R. R. Facklam. From the time of primary isolation until use, none of these organisms was transferred more than seven times. Frozen stock inocula of all isolates were prepared by growing each organism (100 ml; inoculum size, 5% [vol/vol]) for 3 hat 37°C in Todd-Hewitt broth (BBL Microbiology Systems, Cockeysville, Md.). A small amount (1 ml) of each culture was then apportioned into tubes, rapidly frozen in a dry ice-acetone mixture, and stored at -70°C until needed. This permitted the use of an original stock inoculum for each experiment. All organisms were harvested by centrifugation (6,130 x g, 20 min, 4°C) and washed twice with phosphatebuffered saline (PBS; 8.00 g of NaCl per liter, 1.15 g of Na2HP04 per liter, 0.20 g of KCI per liter, 0.20 g of KH2PO4 per liter, pH 7.2) before use. Viable counts were determined on Trypticase soy agar (BBL) plates in duplicate. For studies in which the age of coccal cells was varied, the times of incubation used were as indicated (see Fig. 3 ).
GBS LTA was obtained as previously described (9) . Its high purity, as detailed by amino acid analyses with ophthalaldehyde and fluorescence detection, was as previously detailed for LTA from S. pyogenes (14) .
Tissue culture cells. Human embryonic amnion (GM Q472) and fetal lung (GM 1379) cells from the Coriell Institute for Medical Research, Camden, N.J., were used. The former were propagated in RPMI 1640 medium containing 20% (vol/vol) heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 U of penicillin, and 100 ,ug of streptomycin per ml. The final pH was 7.2. The latter cells utilized Eagle basal medium (MEM) with 20% (vol/vol) non-heat-inactivated fetal bovine serum plus 0.2 mM MEM nonessential amino acid solution and antibiotics (final pH, 7.2). All media and reagents were from GIBCO Laboratories, Grand Island, N.Y. Both cell lines were grown in flat, 75-cm2, 250-ml plastic bottles (Coming Glass Works, Coming, N.Y.) at 37°C in an atmosphere of CO2 (5%) and air (95%). Viable cell counts were usually determined with erythrocin B and a hemacytometer.
(i) Obtaining synchronous amnion and lung cells. For a typical experiment, mitotic cells were obtained by seeding either trypsinized cell line, grown for a maximum of 2 days, into 12 plastic bottles (250 ml; inoculum, 6 x 104 cells per bottle) containing 16 ml of Eagle-S-MEM (i.e., without Ca2') with either 20% (vol/vol) fetal bovine serum or nonheat-inactivated fetal bovine serum (20% vol/vol) plus the nonessential amino acid solution indicated above for amnion and lung cells, respectively. Both media were devoid of antibiotics, and the final pH was 7.2. Inoculum size was critical; use of an inoculum size of 8 x 104 or higher failed to produce a sufficient mitotic cell population for study. After incubation for 16 h at 37°C, the medium was decanted and replaced with 8 ml of the same prewarmed (370C) fresh medium. The use of a prewarmed medium here is emphasized for the continued production of mitotic cells. After additional incubation for 1 h, harvesting of mitotic cells was begun, with all operations carried out at 370C. All bottles were placed in a reciprocating shaker (New Brunswick Scientific Co., New Brunswick, N.J.) and shaken (200 strokes per min) for 1 min. Mitotic cells (only those detached) were harvested by centrifugation (121 x g, 5 min, 0°C). Prewarmed fresh medium (8 ml) was again added to each bottle, followed by an additional hour of incubation before harvesting of mitotic cells as before. This procedure was repeated at 1-h intervals for 8 h. Mitotic cell confirmation was by acetic orcein staining as described by Terasima and Tolmach (20) . The yield of mitotic cells from either cell line was approximately 0.05% of the total population seeded.
Finally, the mitotic index was determined by counting the number of cells, undergoing mitosis and dividing by 500, the total number of cells observed after acetic orcein staining (13) .
(ii) Generation time of synchronous amnion and lung cells. Synchronous amnion cells, suspended in complete RPMI 1640 (1 ml), were inoculated into 16-mm (diameter) wells (0.9 x 102 to 1.1 x 102 cells per well; Falcon no. 3847 flat-bottom wells; Becton Dickinson Labware, Oxnard, Calif.) and incubated at 37°C in a CO2 incubator. At the times indicated (see Fig. 2 ), the cells were counted with a Nikon inverted light microscope (magnification, x 100). A similar procedure was also used to determine the generation time of human fetal lung cells in complete MEM.
Cytotoxicity of LTA for synchronous amnion and lung cells. Synchronous amnion (in complete RPMI 1640 medium) and lung (in complete MEM) cells were incubated for 27 h (3 h postdivision) and 21 h (4 h postdivision), respectively, on glass cover slips in round 16-mm wells. The number of human cells per cover slip for either cell line ranged from 200 to 650 before LTA treatment. Purified coccal LTA, in a concentration range of 3.13 to 100 ,ug/ml in PBS, was used. Wells with cover slips containing adherent mitotic cells were washed three times with PBS, 1 ml of the appropriate concentration of LTA was added, and incubation was continued for 30 min. After one washing with PBS, 2 ml of the appropriate complete tissue culture medium was reintroduced into each well and incubation was continued for 2 days. Media were changed at daily intervals. The extent of cell destruction was assessed after 30 min, 1 day, and 2 days by counting each cover slip with a Nikon inverted light microscope (magnification x 100). The data are expressed as the total number of normal cells still attached to each cover slip. For example, cells still attached but without cytoplasm (i.e., just nucleus) were not counted. Viability was monitored with erythrocin B.
Bacterial adherence assay. From 90 to 130 synchronous amnion or lung cells, washed once with PBS and suspended in 2 ml of the appropriate growth medium with antibiotics (see above), were seeded into glass Leighton tubes (16 by 93 mm, containing no. 1 glass cover slips [9 by 50 mm; Bellco Glass Co., Vineland, N.J.]) and incubated at 37°C usually for 27 and 21 h, respectively (i.e., amnion cells, 3h postdivision; lung cells, 4 h postdivision). For experiments with amnion cells of different ages, incubation ranged from 5 h postdivision to 27 h (3 h postdivision). Each resulting and highly subconfluent monolayer was washed (three times) with PBS before addition of bacteria. Bacterial suspensions were prepared by using logarithmic-phase cells (3 h, 37°C; generation time of all cultures, about 40 min) that had been grown in Todd-Hewitt broth, washed twice with PBS, and suspended in RPMI 1640 medium (without antibiotics) but containing 25 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer, pH 7.2. All suspensions were adjusted to an optical density of 0.3 at 660 nm (viable count,stain, and the attached bacteria per 100 synchronous tissue culture cells were counted by using the oil immersion lens. A streptococcal -chain was counted as 1 CFU. The advantage of this adherence assay has been previously detailed (9) . As before (9) , the data are expressed as the number of attached bacteria, as well as the number of human cells binding bacteria, per 100 tissue culture cells.
Synchronous cell and streptococcal pretreatments. Synchronous cells and cocci were treated just before the adherence assay already described. Human cells (30 to 150 cells per cover slip) were washed three times with PBS and pretreated for 30 min at 37°C with PBS (control) or PBS containing various concentrations of LTA per ml (pH 7.2). Excess LTA was removed by washing once with PBS. Streptococcal pretreatments were done with a bacterial suspension (2 ml; 4 x 108 CFU in Dulbecco PBS with 0.1 g of CaCl2 per liter [PBS-Ca2+]). Suspensions were incubated for 30 min at 37°C with the following additions or treatments: none (control), heat treatment (56°C, 30 min), 2 mg of pronase (pH 7.2 in PBS-Ca2+; type 28; Sigma Chemical Co., St. Louis, Mo.), or anti-LTA serum (1:128 final dilution) prepared as described earlier (9) . Each suspension was centrifuged as described above, washed three times with PBS, and suspended in 2 ml of complete tissue culture medium before use in the adherence assay described above.
Indirect immunofluorescence studies. Coccal cells from a mid-logarithmic-phase culture (3 h old) growing in ToddHewitt broth were harvested by centrifugation and washed twice with PBS-Ca2+. Each PBS-Ca2+ suspension (2 x 108 CFU/ml) was divided, and pronase (final concentration, 1 mg/ml) was added to one portion and the other served as a control. Both portions were incubated for 30 min at 37°C before being centrifuged and washed three times with PBS. Each cell pellet was fixed by dropwise addition of absolute methanol (total, 5 ml) with mixing for 5 min. After fixation, organisms were washed once and suspended in PBS at room temperature, and 0.1 ml of each suspension was dropped onto a glass slide and air dried. Each specimen was overlaid with 0.4 ml of anti-LTA serum (titer 1:256; obtained as detailed elsewhere [9] ) and kept in a moisture chamber for 30 min at 37°C. After removal of excess anti-LTA with PBS, each specimen was overlaid with 0.4 ml of the fluoresceinconjugated immunoglobulin G fraction of goat anti-rabbit immunoglobulin G (catalog no. 1212-0081; Cappel Scientific Division, West Chester, Pa.) in PBS and placed in a moisture chamber at 37°C for 30 min. After removal of excess fluorescein-conjugated antibody by washing with PBS, airdried specimens were examined by UV microscopy at magnifications of x 100, x 160, and x630 (15) . Use of the direct fluorescent-antibody technique proved unsuccessful because of lack of sensitivity. RESULTS Synchrony. Synchronously dividing human embryonic amnion and fetal lung cells were obtained by modifying the selective procedure of Tobey et al. (21) . This procedure takes advantage of the fact that cells adhere much less firmly to a surface during mitosis. Specifically, our modifications included the use of a smaller inoculum size (6 x 104 cells), a slower shaking speed (200 versus 265 strokes per min), but a longer shaking time (1 min versus 5 s) with a greater interval of shaking (1 h versus 10 min). The mitotic figures, as visualized with the nuclear acetic orcein stain, in these cell lines were similar to those of synchronously dividing HeLa cells (20) . However, the yields obtained were considerably lower than from a nonsynchronous culture of HeLa cells (i.e., 1.0% for HeLa cells and 0.05% for amnion and lung cells). The mitotic index for these synchronously dividing amnion and lung cells was 0.91 + 0.01 (n = 3), indicating attainment of almost complete synchrony. The mitotic index obtained without the above-mentioned modifications was 0.77 + 0.03 (n = 2). Finally, the nature of the synchronous cell population for both amnion and lung cells (i.e., the fraction of cells in prophase, metaphase, and combined telophase and anaphase for populations of cells completing mitosis), as determined by the differential mitotic index, was not determined (20, 21) . were used in all subsequent studies. A similar curve was obtained with human fetal lung cells, confirming a generation time for these cells of 17 h established earlier (13) . No attempt was made to determine the total number of synchronous divisions possible with these primary human amnion and lung cell lines. Age of host cell and coccal adherence. Figure 2A compares the binding capacities of virulent and nonvirulent S. agalactiae with the age of the host cell. A 13-fold higher number of the virulent strain was able to bind to younger amnion host cells (3 h postdivision) as compared with the nonvirulent strain. Also strikingly was the difference in adherence between younger and older host cells for only the virulent strain. Finally, this difference became minimal ( Fig. 2A , between 11 and 21 h) but reappeared when the host cells began to enter the next division cycle. Likewise, Fig. 2B illustrates that the percentage of receptive host cells was also significantly greater for up to 9 h postdivision for this synchronously growing cell line but only for virulent S. agalactiae. Thereafter, maximum reception decreased markedly with the age of the host cells, eventually nearly dropping to that of the nonvirulent strain (i.e., 11 h postdivision). As in Fig. 2A, Age of cocci and host cell adherence. The age of a virulent coccal cell also affects its ability to bind to a young (3 h postdivision) host cell (Fig. 3A) . Of note is the fact that the greatest number of virulent cocci adhering to these amnion cells occurred during the early (1 h) and mid-logarithmic (3 h) phases of coccal growth. Although it remained appreciably higher (about 10-fold) than with the nonvirulent strain, coccal adherence to young host cells nevertheless decreased drastically, with the age of the virulent strain, eventually (Fig. 3A and B) . With regard to virulent strains of S. agalactiae type III, early logarithmic (1 h), mid-logarithmic, (3 h), and late stationary (24 h) phase cells showed of 2.3 + 0.6 x 107, 2.6 + 0.4 x 108, and 5.8 + 0.8 x 108 CFU, respectively (n = 3). However, whereas CFU were increasing, adherence had already peaked, and it remained relatively constant during these early phases of growth and decreased markedly at the stationary phase of growth ( Fig. 3A and B) .
Effect of daily transfers in vitro on coccal adherence to young host cells. Figure 4 illustrates the loss of adherence ability (CFU per 100 host cells and percentage of host cells with cocci) with successive transfers of a virulent S. agalactiae at its mid-logarithmic phase of growth. Adherence remained relatively constant through 15 consecutive transfers in Todd-Hewitt broth before abruptly decreasing. After 25 daily transfers, the results obtained were nearly the same as for strains of S. agalactiae type III isolates from asymptomatic individuals. Effect of coccal pretreatment on adherence. Table 2 shows the effects of various treatments on the abilities of virulent and nonvirulent S. agalactiae to adhere to young (3 h postdivision) amnion host cells. Approximately an eightfold difference in adherence between virulent and nonvirulent S. agalactiae exists. Surprisingly, treatment with anti-LTA serum (titer determined by passive hemagglutination with rabbit erythrocytes) did not inhibit adherence of either virulent or nonvirulent strains of S. agalactiae. The concentration of anti-LTA serum used here was considerably more than that used in an earlier study which also failed to inhibit GBS adherence to a human cell monolayer in vitro (9) . Heat abrogated the adherence of all strains of S. agalactiae. However, pronase treatment adversely affected only the virulent strains (about 90o reduction), with resulting adherence to host cells being the same for virulent and nonvirulent cocci after exposure to pronase. It should be noted that, although reducing coccal adherence, the use of pronase did not affect viability (counts of 2.6 x 108 and 2.4 x 108 for virulent cocci before and after treatment, respectively, and 2.7 x 108 and 2.5 x 108 for nonvirulent cocci before and after treatment, respectively). Identical results were obtained after anti-LTA serum and pronase pretreatments for studies in which synchronously dividing human lung cells (4 h postdivision) served in lieu of human amnion cells (Table 3) .
Cytotoxicity of LTA for synchronous human amnion and lung cells. and 12.5 ,ug of this amphiphile per ml were used in these experiments. These concentrations of coccal LTA gave identical results and were unable to prevent the adherence of virulent S. agalactiae to young human amnion (715 ± 67 and 74.2 ± 3.3 mean CFU bound per 100 host cells and percent receptive host cells, respectively; n = 2 or more) or lung cells (660 and 75 mean CFU bound per 100 host cells and percent receptive host cells, respectively; n = 1). Parenthetically, it must be stressed that during these studies virulent strains of S. agalactiae were never observed adhering to morphologically changing or sick amnion or lung cells as a result of exposure to LTA. Fluorescent-antibody studies. Figure 5 shows virulent S. agalactiae after pronase treatment using the indirect-fluorescent-anti-LTA antibody technique. The lack of any appreciable change in fluorescence before (data not shown) and after pronase treatment (Fig. 5) indicates that coccal LTA was not lost by this proteolytic treatment. Finally, a significant difference in fluorescence between virulent and nonvirulent S. agalactiae was not apparent during these repetitive studies.
DISCUSSION
This first use of synchronously dividing human primary, subconfluent monolayers in microbial adherence studies has added credence to an earlier suggestion that human amnion cells may possess ". . . limited and cyclic expression of receptors in vitro" (9) . However, whether these surface receptors actually increase or diminish with age or, instead, only their exposure varies according to the aging process of the cell remains to be determined. Conversely, the finding that the frequency of synchronously dividing and growing human fetal lung cells to bind virulent GBS did not change indicates that cyclic production or exposure of coccal receptor sites on the eucaryotic cell surface with age is not a common property of all human primary cells in vitro. GBS are important agents of disease in neonates (2) (3) (4) 10) . This preference may have as its origin variations in coccal cell receptor sites as different eucaryotic cells develop. As a result, different tissues with different tropisms for the virulent GBS would result based on their content of receptor sites. This would help explain the diminishing degree of GBS pathogenesis as the individual develops from embryo to adult. However, and regardless of age, not all cells of a synchronously dividing embryonic amnion or fetal lung cell population were able to bind virulent GBS. This suggests that there is always a small segment of the eucaryotic cell population in vivo which remains unresponsive to mechanisms involving eucaryotic cell interaction with the pathogenic microorganism.
In addition to surface changes on eucaryotic cells, these findings show that the age of the virulent GBS must also be considered in the adherence process, increasing the complexity of this initial phase of coccal pathogenesis. These data illustrate that coccal surface properties conducive to maximum eucaryotic cell adherence also vary with age in organisms instrumental in the disease process but not in those isolated from asymptomatic individuals. This was apparent in both the numbers of bacteria binding to 100 host cells and the number of eucaryotic cells possessing coccal attachment sites when isolates from asymptomatic versus symptomatic individuals were compared. This increased coccal affinity for a synchronously dividing eucaryotic cell was not dependent upon the microbial growth rate, since the generation times of all isolates examined, whether from asymptomatic or symptomatic individuals, remained con-stant. Viability seemed essential to adherence since heatinactivated organisms lost their adherence abilities. However, others had shown earlier that GBS killed by penicillin or UV light continued to adhere to human cell suspensions and concluded that viability was not a prerequisite for adherence (23) . Finally, in the present study, metabolic activity was a prerequisite for maximum adherence since virulent cocci, when in the late stationary phase of growth, lost approximately 80% of this capability.
Our findings illustrate that the essential ingredients for maximizing adherence of virulent GBS in vitro are organisms in the logarithmic phase of growth and young, dividing eucaryotic cells. The marked surface changes occurring in virulent GBS with age which results in a drastic decrease in the adherence ability of these organisms also suggests that, beyond the minimum number of organisms needed for overt infection, age and coccal numbers become factors in pathogenesis. In this regard, the abundant nutrients and appropriate clearing (or diffusion [or both]) mechanisms for microbial metabolic by-products always present in vivo would help to establish and sustain balanced growth of metabolically active, virulent GBS for a period of time sufficient to enhance host cell destruction, especially in the immunoincomplete neonate.
There was no linear relationship between the number or age of virulent GBS and adherence. Instead, this property is maximized early and persists during the most active growth periods of the pathogen. These findings, together with the almost complete absence of adherence in nonvirulent strains, also suggest that factors other than maximal coccal physiologic activity, rate or phase of growth, or a particular in vitro environment are primarily responsible for virulent GBS adherence to host cells.
It has long been known that continued transferring of a pathogen in vitro leads to loss of virulence. Therefore, the finding that adherence of virulent S. agalactiae type III was abrogated by successive transfers in vitro was not unexpected. As is known, adherence is a prerequisite for pathogenesis. However, what was not anticipated was the manner in which loss of adherence occurred, this property remaining virtually constant after clinical isolation before decreasing abruptly after daily transfer 15 in vitro. These data establish that GBS adherence to eucaryotic cells, like virulence, is a transitory property. Whether this property can be regained by continued passage in tissue culture, as is virulence by passage of the infectious organism in vivo, was not determined.
These data are in accord with our previous findings (9) and those of others (23) but not with results (6, 16) indicating that LTA is responsible for the adherence of virulent S. agalactiae type III in vivo. The LTA used in these studies was of the highest purity (e.g., less than 0.35% protein, only alanine detected by amino acid analysis, no group B and type III antigens present, etc.) (9) . Also, its polyol component had been fully characterized earlier, and its lipid moiety had been partially examined (9) . Treatment of (i) primary human cells with this LTA or (ii) virulent cocci with anti-LTA rabbit serum prepared from this LTA was completely ineffectual in blocking coccal adherence. As already indicated (see Results  and Table 4 ), the highest concentration of LTA used in these blocking experiments was that found least cytotoxic for these amnion and lung cells after 48 h of incubation after removal of residual LTA. The concentration of LTA per individual amnion or lung cell used in these blocking experiments (8 x 10'2 Lg per cell) was much greater than that used in a similar manner previously (5 x 10-4 ,ug per cell) to successfully block adherence of S. pyogenes to monolayers of human kidney cells in tissue culture (7) . Therefore, the inability to prevent adherence of virulent GBS to human cells in the present study cannot be ascribed to use of insufficient LTA or to procedures involved in the isolation or purification of this amphiphile. Conversely, use of pronase drastically abrogated adherence, whereas heat prevented attachment completely. It has been pointed out previously (5) that treatment of virulent GBS with pepsin, a different proteolytic enzyme than that used here, resulted in ... significantly abrogated adherence . . ." but that this treatment also caused loss of ". . . greater than 90% of cellassociated LTA...." This loss of LTA is a pH phenomenon, with no or maximum loss of LTA with pepsin occurring at pHs 7.2 and 3.8, respectively (19) . In the present studies, pronase treatment (at pH 7.2) also abrogated adherence without affecting either viability or coccus-associated, surface-exposed LTA of the virulent GBS isolates, as determined by immunofluorescence analysis. Finally, virulent GBS contain fivefold more LTA than do nonvirulent GBS. Also, because of higher quantities of LTA in virulent GBS in the late exponential phase of growth, it has been suggested that such cells adhered to human eucaryotic cell suspensions with ". . greater binding avidity" because of this increase (16) . However, the present findings clearly show that coccal adherence decreased most markedly, instead of becoming maximized, when virulent GBS reached the stationary phase of growth. Also, immunofluorescence studies showed no observable difference in surface-exposed LTA between virulent and nonvirulent GBS isolates. Therefore, these collective studies suggest that a protein factor, rather than LTA, is primarily responsible for mediating virulent GBS type III attachment to young, synchronously growing, subconfluent eucaryotic monolayers in tissue culture. They are also in agreement with an earlier study which stated that LTA is not instrumental in GBS adherence to human cells but ". . that a heat-sensitive component of the (GBS) streptococcal cell or its wall is involved in its adherence to epithelial cells" (23) .
A report exists on the prevention of GBS colonization with topically applied LTA in a maternal-newborn mouse model (6) . Unfortunately, however, no information was presented on the purity of the milligram quantities of LTA used in this study. Thus, the true involvement of LTA in coccal adherence was difficult to assess. The present in vitro study used growing subconfluent human cell monolayers. Also, a major virtue of the adherence assay used is that nonspecific binding of streptococci is totally avoided. Likewise, all preparations were monitored constantly and completely by light microscopy for changes in cell morphology with time, as well as for tissue cell viability by dye exclusion with erythrocin B. Conversely, the use of trypan blue can result in misleading positive viability results with eucaryotic cells cultured in media with high serum concentrations (13) . Also, its use can be misleading when concentrations of LTA are used which are cytotoxic but are believed to be nontoxic for various cell lines when viability is assessed by trypan blue. For these reasons, erythrocin B was preferred for the studies reported here. Also, others have used prefrozen, thawed, and once-passed, nongrowing human cell suspensions, with coccal adherence monitored only by radioactivity (16) . The opposing conclusions reached by various investigators on the involvement, or lack thereof, of LTA in GBS adherence may be due to a variety of reasons, from the use of nongrowing host cell suspensions with variable metabolic capabilities and comparison of results based on host cell VOL. 56, 1988 suspensions versus growing cell monolayers to the possible presence of multiple adherence mechanisms (adherence versatility or variability?) in GBS.
